미국의 제약용 아이솔레이터 시장 규모, 점유율, 동향 분석 : 제품별, 유형별, 소비자 행동 및 경쟁 분석, 부문별 예측(2026-2033년)

U.S. Pharmaceutical Isolators Market Summary

The U.S. pharmaceutical isolators market size was estimated at USD 177.3 million in 2025 and is projected to reach USD 276.0 million by 2033, growing at a CAGR of 5.9% from 2026 to 2033. The U.S. pharmaceutical isolators industry is being driven by growing regulatory pressure to ensure higher sterility assurance and operator safety in drug manufacturing and compounding.

Stricter guidelines on aseptic processing and hazardous drug handling are pushing healthcare facilities and manufacturers to adopt closed, well-controlled systems. Another key driver is the rapid growth of biologics, cell and gene therapies, and high-potency drugs that require tightly controlled environments. These therapies are highly sensitive to contamination and often involve hazardous materials, increasing demand for advanced containment solutions. Technological improvements such as automated decontamination and modular isolator designs are also improving usability and adoption. Together, these factors are accelerating investment in pharmaceutical isolators across both developed and emerging markets.

U.S. Pharmaceutical Isolators Market Report Segmentation

This report forecasts revenue growth at the U.S. level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pharmaceutical isolators market report based on product, type.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Positive Pressure
• Negative Pressure
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Open Isolator
• Closed Isolator

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Isolators Market Variables, Trends & Scope

• 3.1. Concentration & Growth Prospect Mappin
• 3.2. Industry Value Chain Analysis
• 3.3. Regulatory Framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
  • 3.4.3. Market Challenge Analysis
  • 3.4.4. Market Opportunity Analysis
• 3.5. Industry Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. Macro-environmental Analysis
• 3.6. Economic Mega Trend Analysis

Chapter 4. U.S. Pharmaceutical Isolators Market: Product Estimates & Trend Analysis

• 4.1. Product Movement Analysis & Market Share, 2025 & 2033
• 4.2. U.S. Pharmaceutical Isolators Market Estimates & Forecast, By Product, 2021 to 2033 (USD Million)
• 4.3. Positive Pressure
  • 4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.4. Negative Pressure
  • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pharmaceutical Isolators Market: Type Estimates & Trend Analysis

• 5.1. Type Movement Analysis & Market Share, 2025 & 2033
• 5.2. U.S. Pharmaceutical Isolators Market Estimates & Forecast, By Type, 2021 to 2033 (USD Million)
• 5.3. Open Isolator
  • 5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.4. Closed Isolator
  • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pharmaceutical Isolators Market - Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company Categorization
• 6.3. Company Market Positioning
• 6.4. Competitive Dashboard Analysis
• 6.5. Company Heat Map Analysis, 2025
• 6.6. Strategy Mapping
  • 6.6.1. Expansion
  • 6.6.2. Mergers & Acquisition
  • 6.6.3. Partnerships & Collaborations
  • 6.6.4. New Product Launches
• 6.7. Company Profiles
  • 6.7.1. NuAire, Inc.
    • 6.7.1.1. Participant's overview
    • 6.7.1.2. Financial performance
    • 6.7.1.3. Product benchmarking
    • 6.7.1.4. Recent developments
  • 6.7.2. Germfree
    • 6.7.2.1. Participant's overview
    • 6.7.2.2. Financial performance
    • 6.7.2.3. Product benchmarking
    • 6.7.2.4. Recent developments
  • 6.7.3. Esco Micro Pte. Ltd.
    • 6.7.3.1. Participant's overview
    • 6.7.3.2. Financial performance
    • 6.7.3.3. Product benchmarking
    • 6.7.3.4. Recent developments
  • 6.7.4. Bioquell, An Ecolab Solution
    • 6.7.4.1. Participant's overview
    • 6.7.4.2. Financial performance
    • 6.7.4.3. Product benchmarking
    • 6.7.4.4. Recent developments
  • 6.7.5. Labconco
    • 6.7.5.1. Participant's overview
    • 6.7.5.2. Financial performance
    • 6.7.5.3. Product benchmarking
    • 6.7.5.4. Recent developments
  • 6.7.6. Howorth Air Technology Limited
    • 6.7.6.1. Participant's overview
    • 6.7.6.2. Financial performance
    • 6.7.6.3. Product benchmarking
    • 6.7.6.4. Recent developments
  • 6.7.7. Containment Technologies Group, Inc.
    • 6.7.7.1. Participant's overview
    • 6.7.7.2. Financial performance
    • 6.7.7.3. Product benchmarking
    • 6.7.7.4. Recent developments
  • 6.7.8. Terra Universal. Inc.
    • 6.7.8.1. Participant's overview
    • 6.7.8.2. Financial performance
    • 6.7.8.3. Product benchmarking
    • 6.7.8.4. Recent developments
  • 6.7.9. The Baker Company
    • 6.7.9.1. Participant's overview
    • 6.7.9.2. Financial performance
    • 6.7.9.3. Product benchmarking
    • 6.7.9.4. Recent developments
  • 6.7.10. Schaefer Technologies
    • 6.7.10.1. Participant's overview
    • 6.7.10.2. Financial performance
    • 6.7.10.3. Product benchmarking
    • 6.7.10.4. Recent developments